ADVANCED TUMORS
Clinical trials for ADVANCED TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug enters first human tests
Disease control Recruiting nowThis early-phase study tests a new drug called AL58805 in 40 people with advanced solid tumors who have no other treatment options. The main goal is to find a safe dose and understand how the drug moves through the body. Researchers will monitor side effects closely.
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Advenchen Laboratories Nanjing Ltd. • Aim: Disease control
Last updated May 26, 2026 11:19 UTC
-
New hope for advanced tumors: MDX2004 trial launches
Disease control Recruiting nowThis study tests a new drug, MDX2004, in about 235 adults with advanced solid tumors that have spread or cannot be removed. The main goals are to check the drug's safety and see if it can shrink tumors. Participants must have measurable disease and be in good overall health.
Matched conditions: ADVANCED TUMORS
Phase: PHASE1, PHASE2 • Sponsor: ModeX Therapeutics, An OPKO Health Company • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New drug SIBP-A10 tested in advanced cancer patients – early safety check
Disease control Recruiting nowThis early-stage trial tests a new drug called SIBP-A10 in 160 adults with advanced tumors that have not responded to other treatments. The main goal is to check the drug's safety and find the best dose for future studies. Participants will be closely monitored for side effects a…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Shanghai Institute Of Biological Products • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New hope for advanced cancers? early trial of CS23546 begins
Disease control Recruiting nowThis study is testing a new drug called CS23546 in people with advanced solid tumors or lymphoma that have not responded to or cannot tolerate standard treatments. The main goals are to find a safe dose and understand how the drug works in the body. About 156 participants will ta…
Matched conditions: ADVANCED TUMORS
Phase: PHASE1 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated May 07, 2026 18:41 UTC
-
Promising cancer drug tarlatamab tested in new tumor types
Disease control Recruiting nowThis study tests the drug tarlatamab in people with advanced tumors that have a protein called DLL3. The goal is to see if the drug can shrink or control these tumors. About 29 adults with advanced DLL3-expressing cancers will receive tarlatamab and be monitored for response and …
Matched conditions: ADVANCED TUMORS
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 04, 2026 16:19 UTC